PMA P110013

Device
Resolute Integrity
Applicant
Medtronic Vascular
PMA number
P110013
Supplement
S117
Product code
NIQ
Decision date
2022-09-29
Generic name
Coronary drug-eluting stent
Approval order statement
Approval for updated labeling for the the Resolute Onyx Zotarolimus-Eluting Coronary Stent System electronic Instructions for Use (eIFU) to reflect the long-term data from The RESOLUTE ONYX CTO Post-Approval Study.

Current openFDA PMA Record#

Device
Resolute Integrity
Applicant
Medtronic Vascular
PMA number
P110013
Supplement
S117
Product code
NIQ
Generic name
Coronary drug-eluting stent
Decision date
2022-09-29
Decision code
APPR
Date received
2022-04-07
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - PAS
Approval order statement
Approval for updated labeling for the the Resolute Onyx Zotarolimus-Eluting Coronary Stent System electronic Instructions for Use (eIFU) to reflect the long-term data from The RESOLUTE ONYX CTO Post-Approval Study.